We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Neuromodulation System Stimulates Spinal Cord

By HospiMedica staff writers
Posted on 23 Jul 2007
A small, rechargeable Spinal Cord Stimulation (SCS) system aids patients in the treatment of chronic pain of the trunk, back, and limbs by inducing a sensation similar to parasthesia. More...


The Precision Plus SCS System includes both implanted parts and external parts. The internal parts include leads that are surgically placed under the skin during a minor surgical procedure--usually in the hip area--and an implant connected to the leads placed next to the spinal cord. Physicians can place the implant with enhanced precision thanks to electronically generated lead (EGL) scan technology, which displays the relative position of implanted leads within seconds and without using fluoroscopy or x-ray. The external parts include the remote control, the charger, and the charging base station.

The improved remote controller simplifies the management of patient therapy, eliminating the need for cumbersome cords and antennas. An extended wireless range enables patients to adjust their pain therapy with simplicity and convenience. The new charger, which also features continuous temperature monitoring, is approximately 75% smaller and 85% than regular chargers, making it convenient and discreet. The Precision Plus SCS System is a product of Boston Scientific (Boston, MD, USA).

Since the launch of the Precision system in 2005, we have delivered the technology and support infrastructure needed to gain more than 25% share of the pain management market, said Michael Onuscheck, president of Boston Scientific's pain management business. The advances in the new Precision Plus system will help to enhance the treatment information for the clinician, enabling programming improvements that are designed to significantly impact patient outcomes and clinical results.


Related Links:
Boston Scientific

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.